Abstract
This chapter summarizes current strategies and evidence for the use of orthobiologic injectables for both hip and ankle cartilage lesions and osteoarthritis (OA). Injection therapies have become increasingly common both in the hip and ankle in particular for the treatment of OA, and some preliminary results also showed promising findings for the injective treatment of OLTs. The number of papers published about this topic is increasing, along with the availability of new products. The use of corticosteroids is the oldest injectable therapy for symptomatic OA but presents short-term and only palliative effects. Thus, new therapeutic options are being developed to solve the intrinsic limitations of corticosteroid injections, to reduce symptomatology and improve cartilage viability, protecting joints from further damage. Hyaluronic acid (HA) is a viscoelastic glycosaminoglycan constituent of synovial fluid and cartilage, while platelet-rich plasma (PRP) is a blood derivative rich in bioactive molecules which has also gained high popularity in the last years. More recently, injective cell-based therapies are also being explored for the treatment of hip or ankle OA. Though none of the available options demonstrated to be capable of reversing OA, they may have beneficial effects on symptoms and functionality and may contribute to delay the need for major surgeries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Filardo G, et al. Non-surgical treatments for the management of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2016;24(6):1775–85.
Madry H, et al. Early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2016;24(6):1753–62.
Suppan VKL, et al. Randomized controlled trial comparing efficacy of conventional and new single larger dose of intra-articular viscosupplementation in management of knee osteoarthritis. J Orthop Surg. 2017;25:230949901773162.
Wu B, Li YM, Liu YC. Efficacy of intra-articular hyaluronic acid injections in hip osteoarthritis: A meta-analysis of randomized controlled trials. Oncotarget. 2017;8:86,865–76.
Filardo G, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med. 2015;43:1575–82.
Filardo G, et al. Leukocyte-poor PRP application for the treatment of knee osteoarthritis. Joints. 2013;1:112–20.
Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91:4–15.
O’Keefe RJ, Crabb ID, Edward Puzas J, Rosier RN. Effects of transforming growth factor-β1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I. J Orthop Res. 1994;12:299–310.
Song SU, et al. Hyaline cartilage regeneration using mixed human chondrocytes and transforming growth factor-β1-producing chondrocytes. Tissue Eng. 2005;11:1516–26.
de Girolamo L, et al. Regenerative approaches for the treatment of early OA. Knee Surg Sports Traumatol Arthrosc. 2016;24(6):1826–35.
Perdisa F, et al. Adipose-derived mesenchymal stem cells for the treatment of articular cartilage: a systematic review on preclinical and clinical evidence. Stem Cells Int. 2015;2015(597652)
Filardo G, Perdisa F, Roffi A, Marcacci M, Kon E. Stem cells in articular cartilage regeneration. J Orthop Surg Res. 2016;11:42.
Filardo G, et al. Micro-fragmentation is a valid alternative to cell expansion and enzymatic digestion of adipose tissue for the treatment of knee osteoarthritis: a comparative preclinical study. Knee Surg Sports Traumatol Arthrosc. 2021.
Vannini F, et al. Return to Sports After Bone Marrow–Derived Cell Transplantation for Osteochondral Lesions of the Talus. Cartilage. 2017;8:80–7.
Buda R, et al. “One-step” bone marrow-derived cells transplantation and joint debridement for osteochondral lesions of the talus in ankle osteoarthritis: clinical and radiological outcomes at 36 months. Arch Orthop Trauma Surg. 2016;136:107–16.
Murphy EP, Curtin M, McGoldrick NP, Thong G, Kearns SR. Prospective Evaluation of Intra-Articular Sodium Hyaluronate Injection in the Ankle. J Foot Ankle Surg. 2017;56:327–31.
Correa Bellido P, Wadhwani J, Gil Monzo E. Matrix-induced autologous chondrocyte implantation grafting in osteochondral lesions of the talus: Evaluation of cartilage repair using T2 mapping. J Orthop. 2019;16:500–3.
Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26:355–69.
Migliore A, et al. Efficacy of a single intra-articular HYMOVIS ONE injection for managing symptomatic hip osteoarthritis: A 12-month follow-up retrospective analysis of the ANTIAGE register data. Orthop Res Rev. 2020;12:19–26.
Migliore A, et al. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: Clinical data of 6 months follow-up. Clin Rheumatol. 2006;25:389–93.
Battaglia M, et al. Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics. 2013;36.
Migliore A, et al. Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix®) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther. 2009;11:R183.
Spitzer AI, et al. Hylan G-F 20 improves hip osteoarthritis: A prospective, randomized study. Phys Sportsmed. 2010;38:35–47.
Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: A randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthr Cartil. 2006;14:163–70.
Previtali D, et al. The Long-Lasting Effects of "Placebo Injections" in Knee Osteoarthritis: A Meta-Analysis. Cartilage. 2020;18:1947603520906597.
De Lucia O, et al. Effectiveness and tolerability of repeated courses of viscosupplementation in symptomatic hip osteoarthritis: a retrospective observational cohort study of high molecular weight vs medium molecular weight hyaluronic acid vs no viscosupplementation. Front Pharmacol. 2019;10:1007.
Clementi D, et al. Efficacy of a single intra-articular injection of ultra-high molecular weight hyaluronic acid for hip osteoarthritis: a randomized controlled study. Eur J Orthop Surg Traumatol. 2018;28:915–22.
Abate M, Salini V. Efficacy and safety study on a new compound associating low and high molecular weight hyaluronic acid in the treatment of hip osteoarthritis. Int J Immunopathol Pharmacol. 2017;30:89–93.
Bekerom MPJ, Rys B, Mulier M. Viscosupplementation in the hip: Evaluation of hyaluronic acid formulations. Arch Orthop Trauma Surg. 2008;128:275–80.
Tikiz C, Ünlü Z, Şener A, Efe M, Tüzün Ç. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol. 2005;24:244–50.
Brander V, et al. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline. Osteoarthr Cartil. 2019;27:59–70.
Mauro GL, Scaturro D, Sanfilippo A, Benedetti MG. Intra-articular hyaluronic acid injections for hip osteoarthritis. J Biol Regul Homeost Agents. 2018;32:1303–9.
Migliore A, et al. The impact of treatment with hylan G-F 20 on progression to total hip arthroplasty in patients with symptomatic hip OA: a retrospective study. Curr Med Res Opin. 2012;28:755–60.
Sánchez M, Guadilla J, Fiz N, Andia I. Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford). 2012;51(144–50).
Dallari D, et al. Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis. Am J Sports Med. 2016;44:664–71.
Di Sante L, et al. Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis. Med Ultrason. 2016;18:463–8.
Ye Y, Zhou X, Mao S, Zhang J, Lin B. Platelet rich plasma versus hyaluronic acid in patients with hip osteoarthritis: a meta-analysis of randomized controlled trials. Int J Surg. 2018;53:279–87.
Assirelli E, et al. Effect of two different preparations of platelet-rich plasma on synoviocytes. Knee Surg Sports Traumatol Arthrosc. 2015;23(9):2690–703.
Chahla J, et al. Biological therapies for cartilage lesions in the hip: a new horizon. Orthopedics. 2016;39:e715–23.
Villanova-López MM, et al. Randomized, double-blind, controlled trial, phase III, to evaluate the use of platelet-rich plasma versus hyaluronic acid in hip coxarthrosis. Rev Esp Cir Ortop Traumatol. 2020;64:134–42.
Singh JR, Haffey P, Valimahomed A, Gellhorn AC. The effectiveness of autologous platelet-rich plasma for osteoarthritis of the hip: a retrospective analysis. Pain Med. 2019;20:1611–8.
Hauser RA, Orlofsky A. Regenerative injection therapy with whole bone marrow aspirate for degenerative joint disease: a case series. Clin Med Insights Arthritis Musculoskelet Disord. 2013;6:CMAMD.S10951.
Rodriguez-Fontan F, Piuzzi NS, Kraeutler MJ, Pascual-Garrido C. Early clinical outcomes of intra-articular injections of bone marrow aspirate concentrate for the treatment of early osteoarthritis of the hip and knee: a cohort study. PM R. 2018;10:1353–9.
Mardones R, Jofré CM, Tobar L, Minguell JJ. Mesenchymal stem cell therapy in the treatment of hip osteoarthritis. J Hip Preserv Surg. 2017;4:159–63.
Emadedin M, et al. Long-term follow-up of intra-articular injection of autologous mesenchymal stem cells in patients with knee, ankle, or hip osteoarthritis. Arch Iran Med. 2015;18:336–44.
Berndt AL, Haty M. Transchondral fractures (osteochondritis dissecans) of the talus. J Bone Joint Surg Am. 2004;86:1336.
Verhagen RAW, Struijs PAA, Bossuyt PMM, Van Dijk CN. Systematic review of treatment strategies for osteochondral defects of the talar dome. Foot Ankle Clin. 2003;8:233–42.
Dekker TJ, Dekker PK, Tainter DM, Easley ME, Adams SB. Treatment of Osteochondral lesions of the talus: A critical analysis review. JBJS Rev. 2017;5.
Pettine KA, Morrey BF. Osteochondral fractures of the talus. A long-term follow-up. J Bone Joint Surg Br. 1987;69:89–92.
Bauer M, Jonsson K, Linden B. Osteochondritis dissecans of the ankle. A 20-year follow-up study. J Bone Joint Surg Br. 1987;69:93–6.
Giannini S. Surgical treatment of osteochondral lesions of the talus in young active patients. J Bone Joint Surg. 2005;87:28.
Giannini S, et al. The treatment of severe posttraumatic arthritis of the ankle joint. J Bone Joint Surg Am. 2007;89:15–28.
Boffa A, et al. Evidence on ankle injections for osteochondral lesions and osteoarthritis: a systematic review and meta-analysis. Int Orthop. 2021;45(2):509–23.
Salk RS, Chang TJ, D’Costa WF, Soomekh DJ, Grogan KA. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am. 2006;88:295–302.
DeGroot H, Uzunishvili S, Weir R, Al-omari A, Gomes B. Intra-articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am. 2012;94:2–8.
Sun SF, et al. Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthr Cartil. 2006;14:867–74.
Cohen MM, et al. Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan®) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int. 2008;29:657–63.
Han SH, Park DY, Kim TH. Prognostic factors after intra-articular hyaluronic acid injection in ankle osteoarthritis. Yonsei Med J. 2014;55:1080–6.
Lucas y Hernandez J, Darcel V, Chauveaux D, Laffenêtre O. Viscosupplementation of the ankle: a prospective study with an average follow-up of 45.5 months. Orthop Traumatol Surg Res. 2013;99:593–9.
Bossert M, et al. Imaging guidance improves the results of viscosupplementation with HANOX-M-XL in patients with ankle osteoarthritis: Results of a clinical survey in 50 patients treated in daily practice. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:195–9.
Younger ASE, et al. Nonanimal hyaluronic acid for the treatment of ankle osteoarthritis: a prospective, single-arm cohort study. J Foot Ankle Surg. 2019;58:514–8.
Sun SF, et al. Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. J Foot Ankle Res. 2014;7:9.
Vannini F, et al. Sport and early osteoarthritis: the role of sport in aetiology, progression and treatment of knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2016;24:1786–96.
Mei-Dan O, et al. Treatment of osteochondritis dissecans of the ankle with hyaluronic acid injections: a prospective study. Foot Ankle Int. 2008;29:1171–8.
Angthong C, Khadsongkram A, Angthong W. Outcomes and quality of life after platelet-rich plasma therapy in patients with recalcitrant hindfoot and ankle diseases: a preliminary report of 12 patients. J Foot Ankle Surg. 2013;52:475–80.
Repetto I, Biti B, Cerruti P, Trentini R, Felli L. Conservative treatment of ankle osteoarthritis: can platelet-rich plasma effectively postpone surgery? J Foot Ankle Surg. 2017;56:362–5.
Fukawa T, et al. Safety and efficacy of intra-articular injection of platelet-rich plasma in patients with ankle osteoarthritis. Foot Ankle Int. 2017;38:596–604.
Mei-Dan O, et al. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012;40:534–41.
Akpancar S, Gül D. Comparison of platelet rich plasma and prolotherapy in the management of osteochondral lesions of the talus: a retrospective cohort study. Med Sci Monit. 2019;25:5640–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 ISAKOS
About this chapter
Cite this chapter
Vannini, F., Zielli, S.O., Faldini, C. (2022). Cartilage Lesions and Osteoarthritis of the Hip and Ankle: Orthobiologics. In: Filardo, G., Mandelbaum, B.R., Muschler, G.F., Rodeo, S.A., Nakamura, N. (eds) Orthobiologics. Springer, Cham. https://doi.org/10.1007/978-3-030-84744-9_27
Download citation
DOI: https://doi.org/10.1007/978-3-030-84744-9_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84743-2
Online ISBN: 978-3-030-84744-9
eBook Packages: MedicineMedicine (R0)